Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on October 23, 2019. The filing serves to report the company's financial results for the third quarter ended September 30, 2019, via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1) which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms that third-quarter results were issued on the report date.
Guidance, Outlook, and Risks
The document includes a comprehensive "Forward-Looking Statements" section outlining significant risks and uncertainties that could cause actual results to differ from projections. Key risks identified include:
- Regulatory and Legal: Changes to the Affordable Care Act (ACA), legal challenges to the ACA, and complex regulations regarding Medicare and Medicaid programs.
- Operational and Competitive: Trends in healthcare costs, provider contracting terms, premium rate approvals, and competitive pressures.
- Merger Litigation: Ongoing litigation with Cigna Corporation regarding their failed merger agreement, including claims for damages and termination fees, which could distract management and impact financial condition.
- Pharmacy Benefit Management: Risks related to agreements with Express Scripts and CVS Health, including potential financial penalties or sanctions from CMS.
- Financial and Market: Substantial outstanding indebtedness, potential downgrades in financial strength ratings, and impairment of intangible assets.
- Other: Cybersecurity threats, large-scale medical emergencies, and changes in U.S. tax laws.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific Q3 2019 revenue, earnings, and cash flow figures.
- Verify the status and potential financial impact of the litigation between Anthem and Cigna Corporation.
- Assess the company's progress in transitioning pharmacy benefit management services from Express Scripts to CVS Health.
- Monitor regulatory developments regarding the ACA and their potential effect on premium rates and enrollment.
- Check for any updates on the company's debt levels and financial strength ratings given the cited risks of indebtedness.